Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MGI Tech develops and manufactures high-throughput genetic sequencers, laboratory automation systems, reagents, and bioinformatics platforms. Its DNBSEQ™ series of sequencers are widely used in population genomics, precision medicine, agriculture genomics, metagenomics, spatial omics and more. The company has global reach with over 3,000 customers in more than 100 countries. It does not develop therapeutics but enables life science discovery through its core technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MGI Tech.